摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,8-dimethoxy-1-m-tolyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine | 1080523-54-1

中文名称
——
中文别名
——
英文名称
7,8-dimethoxy-1-m-tolyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine
英文别名
7,8-dimethoxy-5-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine
7,8-dimethoxy-1-m-tolyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine化学式
CAS
1080523-54-1
化学式
C19H23NO2
mdl
——
分子量
297.397
InChiKey
ZULQWNBVGTWJJJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    30.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    7,8-dimethoxy-1-m-tolyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine 在 iron(III) chloride hexahydrate 作用下, 以 硝基苯 为溶剂, 反应 10.0h, 以53%的产率得到6,7-dimethoxy-1-(3-methylphenyl)-3,4-dihydroisoquinoline
    参考文献:
    名称:
    前所未有的FeCl3⋅6H2O促进1-芳基-2,3,4,5-四氢-1H-3苯并ze庚因骨架重排:合成C1四元四氢异喹啉的新策略
    摘要:
    取代基事项:A骨架的1-芳基-3-苯并吖庚因的重排用的FeCl的2.0当量开发3 ⋅6ħ 2 ö在PHNO 2。该ñ -取代了对产品结构的显着影响。在N-烷基苯并ze庚因的情况下,获得了1-芳基四氢异喹啉,而N-酰基-苯并ze庚因产生了一系列独特的C1季铵基1-芳基-1-甲酰基四氢异喹啉。
    DOI:
    10.1002/chem.200901197
点击查看最新优质反应信息

文献信息

  • ‘Click’ D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity
    作者:Jing Zhang、Hai Zhang、Wenxian Cai、Leiping Yu、Xuechu Zhen、Ao Zhang
    DOI:10.1016/j.bmc.2009.06.019
    日期:2009.7
    A series of new 1-aryl-3-benzazepine derivatives containing an arylpiperazinyl function as the N3 substituent were synthesized by combining a D-1 receptor agonistic pharmacophore and a 5-HT1A receptor pharmacophore through Click reaction. Interestingly, these compounds generally do not have good binding affinity at the D-1 receptor, but most compounds are potent at both D-2 and 5-HT1A receptors. Compound 8h, containing 1-m-tolyl-benzazepine scaffold and 2-methoxyphenylpiperazine core, displayed good affinity at all tested receptors, with K-i values of 144, 80, and 133 nM, for the D-1, D-2, and 5-HT1A receptors, respectively. Compound 13 with the triazole moiety formed differently from that in 8h showed the highest affinity at the D-2 receptor with K-i value of 19 nM. This compound also showed moderate affinity at the 5-HT1A (K-i, 105 nM), and D-1 (K-i, 551 nM) receptors. Functional assays indicated that both compounds 13 and 8h are antagonists at D-1 and D-2 receptors, whereas full agonistic activity at the 5-HT1A receptor was observed. In agreement with the binding affinity, compound 13 is a high efficacy D-2 antagonist and 5-HT1A agonist. (C) 2009 Elsevier Ltd. All rights reserved.
  • Unprecedented FeCl<sub>3</sub>⋅6 H<sub>2</sub>O-Promoted Skeleton Rearrangement of 1-Aryl-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepines: A New Strategy for the Synthesis of C1 Quaternary Tetrahydroisoquinolines
    作者:Jing Zhang、Ao Zhang
    DOI:10.1002/chem.200901197
    日期:2009.10.26
    Substituent matters: A skeleton rearrangement of 1‐aryl‐3‐benzazepines was developed with 2.0 equiv of FeCl3⋅6 H2O in PhNO2. The N‐substituents had a dramatic influence on the structures of the products. In the case of N‐alkylbenzazepines, 1‐aryltetrahydroisoquinolines were obtained, whereas N‐acyl‐benzazepines yielded a series of unique C1 quaternary 1‐aryl‐1‐formyltetrahydroisoquinolines.
    取代基事项:A骨架的1-芳基-3-苯并吖庚因的重排用的FeCl的2.0当量开发3 ⋅6ħ 2 ö在PHNO 2。该ñ -取代了对产品结构的显着影响。在N-烷基苯并ze庚因的情况下,获得了1-芳基四氢异喹啉,而N-酰基-苯并ze庚因产生了一系列独特的C1季铵基1-芳基-1-甲酰基四氢异喹啉。
查看更多